http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115040486-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0960aa883967bf5e983386b8f8fd2cc7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
filingDate 2022-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54c139211716b1edeb923f38a8b0a6ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b86bab26b15eef655c7fde2bf594746
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8270a2b2bec2b4e52af909e454633c15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_977bc5ee70ee9779dbe852615d46d822
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d69e9940425d5ddb9e688b45b8e7aa55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c444d62f67b183396de3c1d7251ff831
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a663ae0a31ff6975956caabb43513914
publicationDate 2022-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-115040486-A
titleOfInvention A kind of memantine hydrochloride tablet and preparation method thereof
abstract The invention relates to the technical field of pharmaceutical preparations, and specifically discloses a memantine hydrochloride tablet and a preparation method thereof. The memantine hydrochloride tablet includes: memantine hydrochloride, silicified microcrystalline cellulose and other auxiliary materials; the memantine hydrochloride accounts for 3.5% to 5.5% of the mass of the tablet, and the silicified microcrystalline cellulose accounts for the tablet 88% to 95% of the quality of the agent. The solution of the present invention solves the problem of small doses of medicines, especially medicines with a content of 5 The problem of content uniformity when the small dose of medicine below % is directly compressed.
priorityDate 2022-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID181458
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450501848

Total number of triples: 33.